Ftse Mib
34.518,81
-0,88%
DAX
18.668,36
-0,53%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,00%
Bitcoin
71.102,65
-0,49%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ OpGen Inc (OPGN) OpGen Inc (OPGN) Notizie

OPGN

OpGen (OPGN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OPGN
DataOraFonteTitoloSimboloCompagnia
17/05/202423:02Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:OPGNOpGen Inc
16/05/202413:00GlobeNewswire Inc.OpGen Announced 1-for-10 Reverse Stock SplitNASDAQ:OPGNOpGen Inc
14/05/202422:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPGNOpGen Inc
29/04/202422:05GlobeNewswire Inc.OpGen Provides Update on Business Operations and Strategic OpportunitiesNASDAQ:OPGNOpGen Inc
23/04/202422:15GlobeNewswire Inc.OpGen Receives Nasdaq Notice Regarding Delayed Form 10-KNASDAQ:OPGNOpGen Inc
26/03/202421:20AllPennyStocks.comShares Rip In Reaction To Activist Investor Becoming CEONASDAQ:OPGNOpGen Inc
25/03/202421:05GlobeNewswire Inc.OpGen Announces Acquisition of Preferred Stock by David LazarNASDAQ:OPGNOpGen Inc
24/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OPGNOpGen Inc
14/11/202322:30GlobeNewswire Inc.OpGen Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
13/11/202322:59Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OPGNOpGen Inc
13/10/202323:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OPGNOpGen Inc
13/10/202323:17Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OPGNOpGen Inc
12/10/202318:32GlobeNewswire Inc.OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross ProceedsNASDAQ:OPGNOpGen Inc
28/09/202322:24Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:OPGNOpGen Inc
14/08/202314:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPGNOpGen Inc
10/08/202322:15GlobeNewswire Inc.OpGen Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
07/08/202313:30GlobeNewswire Inc.OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud OfferingNASDAQ:OPGNOpGen Inc
03/08/202314:00GlobeNewswire Inc.OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration AgreementNASDAQ:OPGNOpGen Inc
03/08/202313:30GlobeNewswire Inc.OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern TimeNASDAQ:OPGNOpGen Inc
01/08/202315:40Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:OPGNOpGen Inc
21/07/202322:55Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:OPGNOpGen Inc
19/07/202313:30GlobeNewswire Inc.OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FINDNASDAQ:OPGNOpGen Inc
14/07/202322:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:OPGNOpGen Inc
26/06/202322:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
26/06/202313:30GlobeNewswire Inc.OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in EuropeNASDAQ:OPGNOpGen Inc
22/06/202313:30GlobeNewswire Inc.OpGen’s Subsidiary Curetis Receives Batch of Ten New C-Series Unyvero A30 InstrumentsNASDAQ:OPGNOpGen Inc
20/06/202313:30GlobeNewswire Inc.OpGen Presents Unyvero Urinary Tract Infection Panel Trial Results at ASM Microbe 2023 ConferenceNASDAQ:OPGNOpGen Inc
09/06/202322:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
22/05/202323:00Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OPGNOpGen Inc
15/05/202322:15GlobeNewswire Inc.OpGen Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OPGN

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
G
Generali
BIT
SPM
Saipem
BIT
ENEL
Enel
BIT
BPE
Bper Banca
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
STMMI
ST Microelectronics
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
TEN
Tenaris
BIT
CPR
Davide Campari
BIT
TITR
Telecom Italia
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network